Clinical Trial Update: Lovaza's Effect on the Activation of Platelets [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Lovaza's effect on platelet activation has completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Cardiovascular Disease

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: Invitrox | Conditions: Cardiovascular Disease, Bleeding | Phase 2 | Status: COMPLETED | Results posted: 2013-07-09